States Don’t Need to Wait for FDA to Adopt Nicotine Reduction Endgame Strategies: Lessons from Flavored Tobacco Litigation
Food and Drug Law Journal | Volume 78 | Number 4
Opportunities to Improve the Compounding Quality Act (Open Access)
Food and Drug Law Journal | Volume 78 | Number 4
The Last Man Woman Standing: Why Protecting and Improving Access to Abortion Medication is Necessary Post-Dobbs (Open Access)
Food and Drug Law Journal | Volume 78 | Number 4
Implications of Recent Third Circuit Court of Appeals Decision for FDA Drug Approval Framework (Open Access)
Food and Drug Law Journal | Volume 78 | Number 3
FDA, Medical Communications, and Intended Use—A New Challenge to First and Fifth Amendment Constraints on Government Power (Open Access)
Food and Drug Law Journal | Volume 78 | Number 3
Nutraceuticals and Social Media: FDA and FTC Like and Subscribe to the Next Big Trend in Litigation
Food and Drug Law Journal | Volume 78 | Number 3
Orphan Does Not Always Mean Alone—A Case Study of Eosinophilic Esophagitis, an Orphan Disease
Food and Drug Law Journal | Volume 78 | Number 3
Federal Preemption and the Post-Dobbs Reproductive Freedom Frontier (Open Access)
Food and Drug Law Journal | Volume 78 | Number 2
Enhanced Engagement: The Evolving Relationship between FDA and DoD Regulatory Authorities (Open Access)
Food and Drug Law Journal | Volume 78 | Number 2
Generic Substitution Laws and Combination Products
Food and Drug Law Journal | Volume 78 | Number 2
